User profiles for Kathleen Boerner

Kathleen Börner

MANAGING DIRECTOR AskBio GmbH
Verified email at askbio.com
Cited by 3260

A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples

VL Dao Thi, K Herbst, K Boerner, M Meurer… - Science translational …, 2020 - science.org
The coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 (severe
acute respiratory syndrome coronavirus 2) coronavirus is a major public health challenge. …

[HTML][HTML] Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a …

…, D Kirrmaier, Y Duan, S Ovchinnikova, K Boerner… - Trials, 2021 - Springer
Background To achieve higher effectiveness in population-based SARS-CoV-2 surveillance
and to reliably predict the course of an outbreak, screening, and monitoring of infected …

Screening for SARS-CoV-2 infections with colorimetric RT-LAMP and LAMP sequencing

VLD Thi, K Herbst, K Boerner, M Meurer, LPM Kremer… - Medrxiv, 2020 - medrxiv.org
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus poses a significant public-health
problem. In order to control the pandemic, rapid tests for detecting existing infections …

Scalable RT‐LAMP‐based SARS‐CoV‐2 testing for infection surveillance with applications in pandemic preparedness

…, D Kirrmaier, M Krogemann, K Gubicza, K Boerner… - EMBO …, 2023 - embopress.org
Throughout the SARS‐CoV‐2 pandemic, limited diagnostic capacities prevented sentinel
testing, demonstrating the need for novel testing infrastructures. Here, we describe the setup of …

[HTML][HTML] Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021–07/2023

…, JP Mallm, H Kim, S Steiger, I Seufert, K Boerner… - Infection, Genetics and …, 2024 - Elsevier
In January 2021, the monitoring of circulating variants of SARS-CoV-2 was initiated in
Germany under the Corona Surveillance Act, which was discontinued after July 2023. This …

Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic control

…, D Kirrmaier, M Krogemann, K Gubicza, K Boerner… - medRxiv, 2022 - medrxiv.org
Throughout the current SARS-CoV-2 pandemic, limited diagnostic testing capacity prevented
sentinel testing of the population, demonstrating the need for novel testing strategies and …

56. AAV Vector-Mediated CRISPR Attacks on Proviral HIV-1 DNA for Purging of Cellular Reservoirs

K Boerner, M Nickl, F Schmidt, AC Gnirck, P Bayer… - Molecular Therapy, 2015 - cell.com
HIV, the human immunodeficiency virus, is highly successful as a viral pathogen due to its
ability to persist in the infected host as an integrated proviral DNA within cellular reservoirs, …

307. Rational Development of 12 Different AAV Serotypes as Scaffolds for Peptide Display

K Boerner, E Kienle, A Sacher, LY Huang, M Bechtle… - Molecular Therapy, 2015 - cell.com
multiple sclerosis. Using AAV capsid DNA shuffling we created a library of novel AAV vectors.
The primary recovered AAV capsid clone (Olig001) exhibited a novel> 95% tropism for rat, …

Evolution of SARS-CoV-2 in the RhineNeckar/Heidelberg Region 01/2021 07/2023 (preprint)

…, JP Mallm, H Kim, S Steiger, I Seufert, K Boerner… - 2023 - pesquisa.bvsalud.org
At the beginning of 2021 the monitoring of the circulating variants of SARS-CoV-2 was
established in Germany in accordance with the Corona Surveillance Act (discontinued after July …

Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic control (preprint)

…, D Kirrmaier, M Krogemann, K Gubicza, K Boerner… - 2022 - pesquisa.bvsalud.org
Throughout the current SARS-CoV-2 pandemic, limited diagnostic testing capacity prevented
sentinel testing of the population, demonstrating the need for novel testing strategies and …